PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10469894-1	1999	As judged by findings in preclinical models, determinants of cellular sensitivity to cyclophosphamide and other oxazaphosphorines include two cytosolic aldehyde dehydrogenases, viz., ALDH1A1 and ALDH3A1.	oxazaphosphorines	112-129	aldehyde dehydrogenase 1 family member A1	Homo sapiens	183-190	
11320670-3	2001	Preclinical models indicate that cellular sensitivity to cyclophosphamide and other oxazaphosphorines, e.g., ifosfamide, is inversely related to the cellular content of two aldehyde dehydrogenases, viz ALDH1A1 and ALDH3A1, and glutathione.	oxazaphosphorines	84-101	aldehyde dehydrogenase 1 family member A1	Homo sapiens	202-209	
10469894-2	1999	Each catalyzes the detoxification of the oxazaphosphorines; thus, cellular sensitivity to these agents decreases as cellular levels of ALDH1A1 and/or ALDH3A1 increase.	oxazaphosphorines	41-58	aldehyde dehydrogenase 1 family member A1	Homo sapiens	135-142